Vitamin B6 Aids in Treating Inflammatory Bowel Disease

Inclusion Criteria: * Patients diagnosed with IBD according to the consensus on the diagnosis and treatment of inflammatory bowel disease (Beijing, 2018, DOI: 10.19538/j.nk2018090106); * Have complete medical history data; * Volunteer to participate in this clinical trial and sign the informed consent form. Exclusion Criteria: * Patients with peripheral neuropathy; * Patients with abdominal abscess, toxic megacolon, fulminant colitis, partial colectomy, or total colectomy; * Patients with other autoimmune diseases, hematologic disorders, tumors, acute infections, severe liver or kidney dysfunction, severe conditions such as severe anemia, neutropenia, heart failure, organic heart disease, hepatitis B, cirrhosis, kidney disease, and psychiatric disorders; * Patients who have taken vitamin B6 tablets in the past 3 months; * Patients with a history of substance abuse; * Pregnant or lactating women, or those planning to become pregnant within the next 6 months; * Neurological disorders such as Alzheimer's disease, stroke, Parkinson's disease; * Participation in other clinical trials in the past 6 months; * Incomplete medical records (including gender, age, diagnosis, colonoscopy results, pathological diagnosis results, and other demographic data); * Currently taking: levodopa, phenobarbital, phenytoin sodium.